
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
How Ligands Illuminate GPCR Molecular Pharmacology
Daniel Wacker, Raymond C. Stevens, Bryan L. Roth
Cell (2017) Vol. 170, Iss. 3, pp. 414-427
Open Access | Times Cited: 488
Daniel Wacker, Raymond C. Stevens, Bryan L. Roth
Cell (2017) Vol. 170, Iss. 3, pp. 414-427
Open Access | Times Cited: 488
Showing 1-25 of 488 citing articles:
Trends in GPCR drug discovery: new agents, targets and indications
Alexander S. Hauser, Misty M. Attwood, Mathias Rask‐Andersen, et al.
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 12, pp. 829-842
Open Access | Times Cited: 2253
Alexander S. Hauser, Misty M. Attwood, Mathias Rask‐Andersen, et al.
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 12, pp. 829-842
Open Access | Times Cited: 2253
Molecular Dynamics Simulation for All
Scott A. Hollingsworth, Ron O. Dror
Neuron (2018) Vol. 99, Iss. 6, pp. 1129-1143
Open Access | Times Cited: 1911
Scott A. Hollingsworth, Ron O. Dror
Neuron (2018) Vol. 99, Iss. 6, pp. 1129-1143
Open Access | Times Cited: 1911
G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
Krishna Sriram, Paul A. Insel
Molecular Pharmacology (2018) Vol. 93, Iss. 4, pp. 251-258
Open Access | Times Cited: 1076
Krishna Sriram, Paul A. Insel
Molecular Pharmacology (2018) Vol. 93, Iss. 4, pp. 251-258
Open Access | Times Cited: 1076
Free Fatty Acid Receptors in Health and Disease
Ikuo Kimura, Atsuhiko Ichimura, Ryuji Ohue‐Kitano, et al.
Physiological Reviews (2019) Vol. 100, Iss. 1, pp. 171-210
Open Access | Times Cited: 695
Ikuo Kimura, Atsuhiko Ichimura, Ryuji Ohue‐Kitano, et al.
Physiological Reviews (2019) Vol. 100, Iss. 1, pp. 171-210
Open Access | Times Cited: 695
Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification
Michele A. La Merrill, Laura N. Vandenberg, Martyn T. Smith, et al.
Nature Reviews Endocrinology (2019) Vol. 16, Iss. 1, pp. 45-57
Open Access | Times Cited: 681
Michele A. La Merrill, Laura N. Vandenberg, Martyn T. Smith, et al.
Nature Reviews Endocrinology (2019) Vol. 16, Iss. 1, pp. 45-57
Open Access | Times Cited: 681
A perspective on multi‐target drug discovery and design for complex diseases
Rona R. Ramsay, Marija R. Popovic‐Nikolic, Katarina Nikolić, et al.
Clinical and Translational Medicine (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 597
Rona R. Ramsay, Marija R. Popovic‐Nikolic, Katarina Nikolić, et al.
Clinical and Translational Medicine (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 597
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Denise Wootten, Arthur Christopoulos, Maria Martí-Solano, et al.
Nature Reviews Molecular Cell Biology (2018) Vol. 19, Iss. 10, pp. 638-653
Open Access | Times Cited: 580
Denise Wootten, Arthur Christopoulos, Maria Martí-Solano, et al.
Nature Reviews Molecular Cell Biology (2018) Vol. 19, Iss. 10, pp. 638-653
Open Access | Times Cited: 580
Pharmacogenomics of GPCR Drug Targets
Alexander S. Hauser, Sreenivas Chavali, Ikuo Masuho, et al.
Cell (2017) Vol. 172, Iss. 1-2, pp. 41-54.e19
Open Access | Times Cited: 561
Alexander S. Hauser, Sreenivas Chavali, Ikuo Masuho, et al.
Cell (2017) Vol. 172, Iss. 1-2, pp. 41-54.e19
Open Access | Times Cited: 561
N6-Methyladenine DNA Modification in the Human Genome
Chuan‐Le Xiao, Song Zhu, Minghui He, et al.
Molecular Cell (2018) Vol. 71, Iss. 2, pp. 306-318.e7
Open Access | Times Cited: 456
Chuan‐Le Xiao, Song Zhu, Minghui He, et al.
Molecular Cell (2018) Vol. 71, Iss. 2, pp. 306-318.e7
Open Access | Times Cited: 456
TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome
Reid H. J. Olsen, Jeffrey F. DiBerto, Justin G. English, et al.
Nature Chemical Biology (2020) Vol. 16, Iss. 8, pp. 841-849
Open Access | Times Cited: 423
Reid H. J. Olsen, Jeffrey F. DiBerto, Justin G. English, et al.
Nature Chemical Biology (2020) Vol. 16, Iss. 8, pp. 841-849
Open Access | Times Cited: 423
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone
Sheng Wang, Tao Che, Anat Levit, et al.
Nature (2018) Vol. 555, Iss. 7695, pp. 269-273
Open Access | Times Cited: 390
Sheng Wang, Tao Che, Anat Levit, et al.
Nature (2018) Vol. 555, Iss. 7695, pp. 269-273
Open Access | Times Cited: 390
Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor
Kuglae Kim, Tao Che, Ouliana Panova, et al.
Cell (2020) Vol. 182, Iss. 6, pp. 1574-1588.e19
Open Access | Times Cited: 373
Kuglae Kim, Tao Che, Ouliana Panova, et al.
Cell (2020) Vol. 182, Iss. 6, pp. 1574-1588.e19
Open Access | Times Cited: 373
Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor
Tao Che, Susruta Majumdar, Saheem A. Zaidi, et al.
Cell (2018) Vol. 172, Iss. 1-2, pp. 55-67.e15
Open Access | Times Cited: 338
Tao Che, Susruta Majumdar, Saheem A. Zaidi, et al.
Cell (2018) Vol. 172, Iss. 1-2, pp. 55-67.e15
Open Access | Times Cited: 338
Unexplored therapeutic opportunities in the human genome
Tudor I. Oprea, Cristian Bologa, Søren Brunak, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 5, pp. 317-332
Open Access | Times Cited: 335
Tudor I. Oprea, Cristian Bologa, Søren Brunak, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 5, pp. 317-332
Open Access | Times Cited: 335
EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics
Daniel M. Freed, Nicholas J. Bessman, Anatoly Kiyatkin, et al.
Cell (2017) Vol. 171, Iss. 3, pp. 683-695.e18
Open Access | Times Cited: 331
Daniel M. Freed, Nicholas J. Bessman, Anatoly Kiyatkin, et al.
Cell (2017) Vol. 171, Iss. 3, pp. 683-695.e18
Open Access | Times Cited: 331
Unexplored therapeutic opportunities in the human genome.
Tudor I. Oprea, Cristian Bologa, Søren Brunak, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 5, pp. 377-377
Open Access | Times Cited: 300
Tudor I. Oprea, Cristian Bologa, Søren Brunak, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 5, pp. 377-377
Open Access | Times Cited: 300
Impact of GPCR Structures on Drug Discovery
Miles Congreve, Chris de Graaf, Nigel A. Swain, et al.
Cell (2020) Vol. 181, Iss. 1, pp. 81-91
Open Access | Times Cited: 297
Miles Congreve, Chris de Graaf, Nigel A. Swain, et al.
Cell (2020) Vol. 181, Iss. 1, pp. 81-91
Open Access | Times Cited: 297
A Forward Chemical Genetic Screen Reveals Gut Microbiota Metabolites That Modulate Host Physiology
Haiwei Chen, Phu-Khat Nwe, Yi Yang, et al.
Cell (2019) Vol. 177, Iss. 5, pp. 1217-1231.e18
Open Access | Times Cited: 280
Haiwei Chen, Phu-Khat Nwe, Yi Yang, et al.
Cell (2019) Vol. 177, Iss. 5, pp. 1217-1231.e18
Open Access | Times Cited: 280
Biased Receptor Signaling in Drug Discovery
Terry Kenakin
Pharmacological Reviews (2019) Vol. 71, Iss. 2, pp. 267-315
Open Access | Times Cited: 246
Terry Kenakin
Pharmacological Reviews (2019) Vol. 71, Iss. 2, pp. 267-315
Open Access | Times Cited: 246
GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures
Ichio Shimada, Takumi Ueda, Yutaka Kofuku, et al.
Nature Reviews Drug Discovery (2018) Vol. 18, Iss. 1, pp. 59-82
Open Access | Times Cited: 217
Ichio Shimada, Takumi Ueda, Yutaka Kofuku, et al.
Nature Reviews Drug Discovery (2018) Vol. 18, Iss. 1, pp. 59-82
Open Access | Times Cited: 217
Morphine‐induced respiratory depression is independent of β‐arrestin2 signalling
Andrea Kliewer, Alexander Gillis, R. W. Hill, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 13, pp. 2923-2931
Open Access | Times Cited: 212
Andrea Kliewer, Alexander Gillis, R. W. Hill, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 13, pp. 2923-2931
Open Access | Times Cited: 212
5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology
Yao Peng, John D. McCorvy, Kasper Harpsøe, et al.
Cell (2018) Vol. 172, Iss. 4, pp. 719-730.e14
Open Access | Times Cited: 208
Yao Peng, John D. McCorvy, Kasper Harpsøe, et al.
Cell (2018) Vol. 172, Iss. 4, pp. 719-730.e14
Open Access | Times Cited: 208
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Nicholas M. Barnes, Gerard P. Ahern, Carine Bécamel, et al.
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 310-520
Open Access | Times Cited: 202
Nicholas M. Barnes, Gerard P. Ahern, Carine Bécamel, et al.
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 310-520
Open Access | Times Cited: 202
Psychedelics as anti-inflammatory agents
Thomas W. Flanagan, Charles D. Nichols
International Review of Psychiatry (2018) Vol. 30, Iss. 4, pp. 363-375
Closed Access | Times Cited: 194
Thomas W. Flanagan, Charles D. Nichols
International Review of Psychiatry (2018) Vol. 30, Iss. 4, pp. 363-375
Closed Access | Times Cited: 194
An ALOX12–12-HETE–GPR31 signaling axis is a key mediator of hepatic ischemia–reperfusion injury
Xiao‐Jing Zhang, Xu Cheng, Zhenzhen Yan, et al.
Nature Medicine (2017) Vol. 24, Iss. 1, pp. 73-83
Closed Access | Times Cited: 190
Xiao‐Jing Zhang, Xu Cheng, Zhenzhen Yan, et al.
Nature Medicine (2017) Vol. 24, Iss. 1, pp. 73-83
Closed Access | Times Cited: 190